Cytokinetics Inc (CYTK)

Exchange
NASDAQ
Symbol
CYTK
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering, developing and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is headquartered in South San Francisco, California.
Country
USA

Stock price

At close: September 17, 2025

  • Open
    49.70
  • High
    51.71
  • Low
    47.45
  • Close
    47.56
  • Volume
    7,377,040

Financial ratios

Dec 31, 2024